Development of an innovative nanostructured dermal matrix in combination with a hyperstable form of growth factor for fibroblasts (FGF2): Ex ovo and in vivo study
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| Citation |
| Authors | |
|---|---|
| Year of publication | 2019 |
| Type | Conference abstract |
| Citation |